Market closedNon-fractional
Ironwood Pharmaceuticals/IRWD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Ticker
IRWD
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Boston, United States
Employees
267
Website
www.ironwoodpharma.com
IRWD Metrics
BasicAdvanced
$1.1B
Market cap
-
P/E ratio
-$6.75
EPS
0.51
Beta
-
Dividend rate
Price and volume
Market cap
$1.1B
Beta
0.51
Financial strength
Current ratio
0.825
Quick ratio
0.767
Long term debt to equity
-147.49
Total debt to equity
-208.891
Interest coverage (TTM)
5.39%
Management effectiveness
Return on assets (TTM)
11.54%
Return on equity (TTM)
-574.72%
Valuation
Price to revenue (TTM)
2.565
Price to book
-3.26
Price to tangible book (TTM)
-3.23
Price to free cash flow (TTM)
7.173
Growth
Revenue change (TTM)
-0.86%
Earnings per share change (TTM)
-771.63%
3-year revenue growth (CAGR)
1.25%
3-year earnings per share growth (CAGR)
96.48%
What the Analysts think about IRWD
Analyst Ratings
Majority rating from 7 analysts.
IRWD Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$75M
-36.34%
Net income
-$4.1M
310.00%
Profit margin
-5.48%
544.71%
IRWD Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$6.71
$0.09
-$0.01
-$0.02
-
Expected
$0.25
$0.16
$0.21
$0.19
$0.15
Surprise
-2,820.27%
-42.86%
-104.86%
-110.47%
-
IRWD News
AllArticlesVideos
The Schall Law Firm Starts Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Begin Conversation
Accesswire·4 weeks ago
The Schall Law Firm Initiates Inquiry Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Incurred Losses To Initiate Dialogue
Accesswire·4 weeks ago
The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Suffered Losses To Initiate Contact
Accesswire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ironwood Pharmaceuticals stock?
Ironwood Pharmaceuticals (IRWD) has a market cap of $1.1B as of July 27, 2024.
What is the P/E ratio for Ironwood Pharmaceuticals stock?
The price to earnings (P/E) ratio for Ironwood Pharmaceuticals (IRWD) stock is 0 as of July 27, 2024.
Does Ironwood Pharmaceuticals stock pay dividends?
No, Ironwood Pharmaceuticals (IRWD) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Ironwood Pharmaceuticals dividend payment date?
Ironwood Pharmaceuticals (IRWD) stock does not pay dividends to its shareholders.
What is the beta indicator for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals (IRWD) has a beta rating of 0.51. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Ironwood Pharmaceuticals stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.